Xconomy: Acceleron Pharma News, Articles and Opinions

“acceleron-pharma” Archives

Entry	Author	Date	Location
Celgene Files for FDA Approval of Blood Disease Drug	Frank Vinluan	04/05/19	New York
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski	Ben Fidler	03/11/19	National
Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups	Ben Fidler	07/27/18	National
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More	Frank Vinluan	07/13/18	National
Acceleron, Celgene Drug Shines in Phase 3 Test in Rare Blood Disorder	Frank Vinluan	07/09/18	Boston
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1)	Ben Fidler	12/04/17	National
With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug	Ben Fidler	08/01/17	Boston
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No	Ben Fidler	06/16/17	National
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More	Ben Fidler	12/06/16	National
Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs	Ben Fidler	10/17/16	New York
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More	Ben Fidler	01/08/16	Boston
Verastem Sinks as Mesothelioma Study Halted For Futility	Ben Fidler	09/28/15	Boston
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More	Ben Fidler	05/22/15	Boston
East Coast Biotech Roundup: Celgene, Blueprint(s), Intarcia & More	Ben Fidler	05/01/15	Boston
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech	Alex Lash	04/29/15	New York
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More	Ben Fidler	04/13/15	Boston
Flagship Ventures Raises Sails for $537M Fund, Its Largest to Date	Alex Lash	03/26/15	Boston
Investors Line up For Westphal as Muscle Cramp Startup Upsizes IPO	Ben Fidler	01/28/15	Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead	Ben Fidler	12/11/14	San Francisco
Polaris Partners Adds $450M for Seventh Fund	Curt Woodward	11/24/14	Boston
To Fight Cramps, Christoph Westphal Taps Boston All-Stars for $40M	Ben Fidler	09/09/14	Boston
East Coast Biotech Roundup: Acceleron, Seres, Sage, & More	Ben Fidler	07/18/14	Boston
How a Little Serendipity Led Acceleron to a Crippling Blood Disease	Ben Fidler	07/17/14	Boston
Lightstone Closes $172M Fund for Early-Stage Biotechs	Ben Fidler	05/01/14	Boston
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More	Ben Fidler	04/04/14	Boston
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More	Ben Fidler	02/28/14	Boston
East Coast Life Sciences Roundup: NY Genome Center, Acceleron, Bind, & More	Ben Fidler	09/20/13	Boston
Acceleron Prices Upsized IPO at $15 Per Share, Begins Trading Thursday	Ben Fidler	09/19/13	Boston
East Coast Life Sciences Roundup: KiiLN, Celgene, Acceleron, & More	Ben Fidler	08/09/13	New York
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M	Ben Fidler	08/07/13	Boston
Page 1 of 3	next page »